Innovation in Development and Qualification of Alternative Testing Methodologies for Reproductive Toxicology (U01)

The summary for the Innovation in Development and Qualification of Alternative Testing Methodologies for Reproductive Toxicology (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Innovation in Development and Qualification of Alternative Testing Methodologies for Reproductive Toxicology (U01)
	CFDA Number:	93.103
	CFDA Description:	Food and Drug Administration_Research
	Federal Agency Name:	Food and Drug Administration
	Category of Funding Activity:	Health Science and Technology
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-FD-11-017
	Document Type:	Modification to Previous Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	May 05, 2011
	Creation Date:	May 05, 2011
	Original Closing Date for Applications:	Jun 16, 2011
	Current Closing Date for Applications:	Jun 16, 2011
	Archive Date:	Jul 16, 2011
	Expected Number of Awards:	20
	Estimated Total Program Funding:	1,000,000
	Federal Grant Award Ceiling:	350,000
	Federal Grant Award Floor:	250,000
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Additional Information on Eligibility: PLEASE Note: The entities eligible to enter into partnerships with FDA are governed by Section 566 of the FD&C Act [21 U.S.C. 360bbb-5]. An eligible organization that wishes to enter into a collaborative agreement must provide an assurance that the entity will not accept funding for a Crtical Path Public-Private Partnership Project from any organization that manufactures or distributes products regulated by the Food and Drug Administration (FDA)unless the entity provides assurances in its agreement with FDA that the results of the Critical Path Public-Private Partnership Project will not be influenced by any source of funding.
Grant Description: As part of Food and Drug Administration's Advancing Regulatory Science initiative the Office of Critical Path Programs (OCPP) supports innovation to improve the development and evaluation of new safe and effective medical products for diagnosing, treating, and preventing conditions and diseases. OCPP is working to harness new science and new technologies to further this goal.This Funding Opportunity Announcement (FOA) will provide resources for research into the development and qualification of alternative methodologies in the area of reproductive toxicology, which have the potential to be more predictive than the currently required testing, and which will reduce, refine, or replace animal testing.Applications should address the Critical Path Initiative's mission to facilitate the development of new safe and effective products for diagnosing, treating, and preventing disease.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-fd-11-017.htm.
Grant Announcement Contact: Gladys M. Bohler Grants Management Officer/Specialist Phone 301-827-7175

FDA office e-mail [gmbohler@fda.hhs.gov]
Similar Government Grants: • Assisting the Integrated Food Safety System's National Food/Feed Training Program (U54); • Evaluation of Salmonella in Symptomatic and Asymptomatic Pets: Study for the Vet-LRN Program (U18); • Specialized Centers of Research (SCOR) on Sex Differences (P50); • Novel Interventions and Collaborations to Improving the Safe Use of Medications (U01); • Alliance for Advancing a National Integrated Food Safety System (U18); • Support for Small Scientific Conference Grant Program; • Cooperative Agreement to Support the World Health Organization (WHO) International Programme on Chem...; • Clinical Studies of Safety and Effectiveness of Orphan Products; • FDA State Food Safety Task Force Conference; • Food Safety and Security Research - Rapid Methods Development